Turning Point Therapeutics

Biotechnology Research

Overview

Industry

Biotechnology Research

Founded Year

2013

Company Type

Public Company

Website

http://www.bms.com

Social Media

Specialty

ALK, Drug resistance, FAK, G1202R, G2032R, JAK2, MASC, NSCLC, NTRK, NTRK1, NTRK2, NTRK3, Oncology, Precision medicine, ROS1, SRC, Structure-based design, fusion gene, metastasis, oncogenic

Overview

We officially combined with Bristol Myers Squibb to advance our precision oncology platform for patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for cancer patients. For more information on the acquisition, r read more company news read more company news read more company news read more company news...

Org Chart

Sign up to view details

Click to see org chart details

Headcount

Sign up to view details

Click to see headcount details

News

Sign up to view details

Click to see news details

Hirings

Sign up to view details

Click to see hirings details

FAQs

When was Turning Point Therapeutics founded?

Turning Point Therapeutics was founded in 2013.

What is Turning Point Therapeutics's official website?

Turning Point Therapeutics's official website is http://www.bms.com.

Find Contacts Everywhere

Find emails and phone numbers on LinkedIn, Company Websites and Your CRM!

Install Extension (It's Free)